ELVN logo

Enliven Therapeutics, Inc. (ELVN) Current Ratio

Annual Current Ratio:

19.99+9.71(+94.46%)
December 31, 2024

Summary

  • As of today, ELVN annual current ratio is 19.99, with the most recent change of +9.71 (+94.46%) on December 31, 2024.
  • During the last 3 years, ELVN annual current ratio has risen by +0.75 (+3.90%).
  • ELVN annual current ratio is now -59.19% below its all-time high of 48.98, reached on December 31, 2022.

Performance

ELVN Current Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNfinancial health metrics

Quarterly Current Ratio:

32.95+0.37(+1.14%)
September 30, 2025

Summary

  • As of today, ELVN quarterly current ratio is 32.95, with the most recent change of +0.37 (+1.14%) on September 30, 2025.
  • Over the past year, ELVN quarterly current ratio has increased by +15.51 (+88.93%).
  • ELVN quarterly current ratio is now -32.73% below its all-time high of 48.98, reached on December 31, 2022.

Performance

ELVN Quarterly Current Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNfinancial health metrics

Current Ratio Formula

Current Ratio =  
Current Assets
Current Liabilities

ELVN Current Ratio Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+94.5%+88.9%
3Y3 Years+3.9%+1.4%
5Y5 Years+174.2%+75.5%

ELVN Current Ratio Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-59.2%+94.5%-32.7%+220.5%
5Y5-Year-59.2%+174.2%-32.7%+222.1%
All-TimeAll-Time-59.2%+374.8%-32.7%+222.1%

ELVN Current Ratio History

DateAnnualQuarterly
Sep 2025
-
32.95(+1.1%)
Jun 2025
-
32.58(+54.7%)
Mar 2025
-
21.06(+5.4%)
Dec 2024
19.99(+94.5%)
19.99(+14.6%)
Sep 2024
-
17.44(+21.2%)
Jun 2024
-
14.39(+6.8%)
Mar 2024
-
13.47(+31.0%)
Dec 2023
10.28(-79.0%)
10.28(-53.8%)
Sep 2023
-
22.24(-28.2%)
Jun 2023
-
30.96(+13.7%)
Mar 2023
-
27.23(-44.4%)
Dec 2022
48.98
48.98(+50.7%)
Sep 2022
-
32.51(+67.1%)
DateAnnualQuarterly
Jun 2022
-
19.46(+79.0%)
Mar 2022
-
10.87(-15.5%)
Dec 2021
19.24(+33.0%)
-
Dec 2021
-
12.86(-12.8%)
Sep 2021
-
14.75(+44.2%)
Jun 2021
-
10.23(-29.9%)
Mar 2021
-
14.60(+0.9%)
Dec 2020
14.47(+98.5%)
14.47(-22.9%)
Sep 2020
-
18.78(-17.7%)
Jun 2020
-
22.81(+2.8%)
Mar 2020
-
22.19
Dec 2019
7.29(+73.2%)
-
Dec 2018
4.21(-66.0%)
-
Dec 2017
12.38
-

FAQ

  • What is Enliven Therapeutics, Inc. annual current ratio?
  • What is the all-time high annual current ratio for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. annual current ratio year-on-year change?
  • What is Enliven Therapeutics, Inc. quarterly current ratio?
  • What is the all-time high quarterly current ratio for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. quarterly current ratio year-on-year change?

What is Enliven Therapeutics, Inc. annual current ratio?

The current annual current ratio of ELVN is 19.99

What is the all-time high annual current ratio for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high annual current ratio is 48.98

What is Enliven Therapeutics, Inc. annual current ratio year-on-year change?

Over the past year, ELVN annual current ratio has changed by +9.71 (+94.46%)

What is Enliven Therapeutics, Inc. quarterly current ratio?

The current quarterly current ratio of ELVN is 32.95

What is the all-time high quarterly current ratio for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high quarterly current ratio is 48.98

What is Enliven Therapeutics, Inc. quarterly current ratio year-on-year change?

Over the past year, ELVN quarterly current ratio has changed by +15.51 (+88.93%)
On this page